1. Home
  2. GHLD vs AVXL Comparison

GHLD vs AVXL Comparison

Compare GHLD & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • AVXL
  • Stock Information
  • Founded
  • GHLD 1960
  • AVXL 2004
  • Country
  • GHLD United States
  • AVXL United States
  • Employees
  • GHLD N/A
  • AVXL N/A
  • Industry
  • GHLD Finance: Consumer Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GHLD Finance
  • AVXL Health Care
  • Exchange
  • GHLD Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • GHLD 838.8M
  • AVXL 779.5M
  • IPO Year
  • GHLD 2020
  • AVXL N/A
  • Fundamental
  • Price
  • GHLD $12.90
  • AVXL $8.95
  • Analyst Decision
  • GHLD Buy
  • AVXL Strong Buy
  • Analyst Count
  • GHLD 5
  • AVXL 2
  • Target Price
  • GHLD $16.30
  • AVXL $44.00
  • AVG Volume (30 Days)
  • GHLD 19.2K
  • AVXL 1.3M
  • Earning Date
  • GHLD 05-08-2025
  • AVXL 05-08-2025
  • Dividend Yield
  • GHLD 3.90%
  • AVXL N/A
  • EPS Growth
  • GHLD N/A
  • AVXL N/A
  • EPS
  • GHLD 1.56
  • AVXL N/A
  • Revenue
  • GHLD $1,159,554,000.00
  • AVXL N/A
  • Revenue This Year
  • GHLD $7.97
  • AVXL N/A
  • Revenue Next Year
  • GHLD $19.57
  • AVXL N/A
  • P/E Ratio
  • GHLD $8.27
  • AVXL N/A
  • Revenue Growth
  • GHLD 60.70
  • AVXL N/A
  • 52 Week Low
  • GHLD $11.21
  • AVXL $3.25
  • 52 Week High
  • GHLD $18.26
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 45.10
  • AVXL 51.91
  • Support Level
  • GHLD $12.78
  • AVXL $8.61
  • Resistance Level
  • GHLD $13.80
  • AVXL $9.17
  • Average True Range (ATR)
  • GHLD 0.78
  • AVXL 0.71
  • MACD
  • GHLD -0.21
  • AVXL 0.06
  • Stochastic Oscillator
  • GHLD 15.15
  • AVXL 88.68

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: